These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12187806)

  • 1. [Effect of sustained release of theophylline on pulmonary physiologic function in elderly patients with chronic obstructive pulmonary disease].
    Teramoto S
    Nihon Ronen Igakkai Zasshi; 2002 Jul; 39(4):414-8. PubMed ID: 12187806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of an inhaled beta 2-adrenergic agent on pulmonary function and quality of life in elderly patients with chronic obstructive pulmonary disease].
    Teramoto S
    Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):204-8. PubMed ID: 11974946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of theophylline on respiratory function in patients with chronic obstructive lung disease].
    Sooronbaev TM; Altymysheva AT; Shabykeeva SB; Kadyraliev ZhK; Mirrakhimov MM
    Probl Tuberk Bolezn Legk; 2006; (7):13-6. PubMed ID: 16944706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
    J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
    Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
    Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of theophylline on plasma levels of interleukin-4, cyclic nucleotides and pulmonary functions in patients with chronic obstructive pulmonary disease.
    Zhang N; Xu Y; Zhang Z; Liu J; Fang H; Ni W
    J Tongji Med Univ; 1999; 19(1):15-9. PubMed ID: 12840867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.
    Minami S; Kawayama T; Ichiki M; Nishiyama M; Sueyasu Y; Gohara R; Kinoshita M; Koga H; Iwanaga T; Aizawa H
    Intern Med; 2008; 47(6):503-9. PubMed ID: 18344636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study.
    Cazzola M; Gabriella Matera M
    Respir Med; 2007 May; 101(5):957-62. PubMed ID: 17056241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD.
    Ohta K; Fukuchi Y; Grouse L; Mizutani R; Rabe KF; Rennard SI; Zhong NS
    Respir Med; 2004 Oct; 98(10):1016-24. PubMed ID: 15481279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
    Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
    Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of inhaled anticholinergic drug on pulmonary function and quality of life in elderly patients with chronic obstructive pulmonary disease].
    Teramoto S
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):519-22. PubMed ID: 11523165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of theophylline on respiratory drive in patients with chronic obstructive pulmonary disease.
    Ashutosh K; Sedat M; Fragale-Jackson J
    J Clin Pharmacol; 1997 Dec; 37(12):1100-7. PubMed ID: 9506004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
    Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ;
    Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD.
    Cazzola M; Noschese P; Centanni S; Santus P; Di Marco F; Spicuzza L; Di Maria GU
    Pulm Pharmacol Ther; 2004; 17(3):141-5. PubMed ID: 15123223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.